Status:
COMPLETED
EValuation of the Antioxidant and Anti-inflammatory Capacity of Nutraceutical IMMU·SYSTEM Food Supplement (EVAANIS)
Lead Sponsor:
Complife Italia Srl
Collaborating Sponsors:
Macrofarm Srl
Icim International Srl
Conditions:
Oxidative Stress
Eligibility:
All Genders
30-65 years
Phase:
NA
Brief Summary
The aim of the study is to verify the effectiveness of Nutraceutical IMMU·SYSTEM Dietary supplement in reducing the levels of oxidative stress and inflammation in a sample of healthy adult subjects wi...
Eligibility Criteria
Inclusion
- Caucasian ethnicity;
- Age between 30 and 65 years;
- Smokers who have smoked at least 100 cigarettes in their lifetime and smoke at least 10 cigarettes a day;
- Sportsmen who have been playing sports for at least 6 months between 4 and 8 hours per week;
- Signature of informed consent.
Exclusion
- Systemic pathologies;
- Active drug therapy;
- Estrogen-progestogen therapy;
- Pregnancy;
- Allergies to the components of the raw material under study.
Key Trial Info
Start Date :
October 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04912947
Start Date
October 30 2020
End Date
April 30 2021
Last Update
June 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Calabria
Rende, CS, Italy, 87036